Endothelin Receptor Antagonists (ERA) in Hypertension and Chronic Kidney Disease: a Rose with Many Thorns
The Open Hypertension Journal · 2013
DOI: 10.2174/1876526201305010012 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Hypertension Journal, 2013. Verfasst von Doumas M und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The discovery of endothelin created a lot of enthusiasm and paved new therapeutic avenues for the treatment of arterial hypertension. Endothelin plays a significant role in blood pressure regulation through pronounced vasoconstriction and modulation of sodium and water reabsorption in the kidneys. Endothelin receptor antagonists have been tested in many clinical trials in patients with arterial hypertension, heart failure, pulmonary arterial hypertension, systemic sclerosis, chronic kidney disease, and diabetic nephropathy. However, the results were usually disappointing, except in pulmonary hypertension and scleroderma digital ulcers. The future of ERAs for the treatment of arterial hypertension and chronic kidney disease does not seem bright, and only the combination with other classes of antihypertensive drugs might offer a way out.
Zitieren
APA
M, D., V, A., N, K., A, R., A, L., & A, K. (2013). Endothelin Receptor Antagonists (ERA) in Hypertension and Chronic Kidney Disease: a Rose with Many Thorns. The Open Hypertension Journal. https://doi.org/10.2174/1876526201305010012
Vancouver
M D, V A, N K, A R, A L, A K. Endothelin Receptor Antagonists (ERA) in Hypertension and Chronic Kidney Disease: a Rose with Many Thorns. The Open Hypertension Journal. 2013. doi:10.2174/1876526201305010012
BibTeX
@article{M2013,
author = {M, Doumas and V, Athyros and N, Katsiki and A, Reklou and A, Lazaridis and A, Karagiannis},
title = {Endothelin Receptor Antagonists (ERA) in Hypertension and Chronic Kidney Disease: a Rose with Many Thorns},
journal = {The Open Hypertension Journal},
year = {2013},
doi = {10.2174/1876526201305010012}
}
EUVIMED